Fluticasone propionate is an active pharmaceutical ingredient used in pharmaceutical manufacturing. It is associated with potential developmental toxicity as indicated by government labeling requirements.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 80474-14-2
(6a,11b,16a,17a)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-diene-17-carbothioic acid
pharmaceutical intermediate
Halobetasol propionate
pharmaceutical raw material
Fluticasone furoate
pharmaceutical raw material
Theobromine sodium salicylate
pharmaceutical raw material
Acriflavine hydrochloride
pharmaceutical raw material
Balsalazide
pharmaceutical raw material
Rifaximin
pharmaceutical raw material
The international HS code for FLUTICASONE PROPIONATE (CAS 80474-14-2) is 2937.22.
2937.22
2937 22 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
WMWTYOKRWGGJOA-CENSZEJFSA-N
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF